We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUUU.WS
10601
DELISTED
Energy Fuels Inc.
UUUU.WS
$27K ﹤0.01%
13,148
-2,816
-18% -$2.34K
SPRT
10602
DELISTED
support.com, Inc.
SPRT
$27K ﹤0.01%
+12,217
New +$24.9K
YDKG
10603
Yueda Digital Holding
YDKG
$5.81M
$26K ﹤0.01%
+30
New +$14K
CYTO
10604
DELISTED
Altamira Therapeutics Ltd
CYTO
$26K ﹤0.01%
+25
New +$16.1K
INFI
10605
PUT
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$26K ﹤0.01%
+12,200
New +$20.1K
TYME
10606
CALL
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$26K ﹤0.01%
+21,300
New +$21.8K
RRD
10607
PUT
DELISTED
RR Donnelley & Sons Co.
RRD
$26K ﹤0.01%
+11,500
New +$17.3K
KOR
10608
DELISTED
Corvus Gold Inc. Common Shares
KOR
$26K ﹤0.01%
11,079
-31,521
-74% -$78.5K
LCTX icon
10609
Lineage Cell Therapeutics
LCTX
$277M
$25K ﹤0.01%
+13,896
New +$19.4K
OCGN icon
10610
Ocugen
OCGN
$423M
$25K ﹤0.01%
+13,884
New +$6.69K
PSTV icon
10611
Plus Therapeutics
PSTV
$26.6M
$25K ﹤0.01%
33
-27
-45% -$23.1K
CCLP
10612
CALL
DELISTED
CSI Compressco LP
CCLP
$25K ﹤0.01%
+23,200
New +$21.9K
NM
10613
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$25K ﹤0.01%
+11,200
New +$22.7K
RIBT
10614
DELISTED
RiceBran Technologies
RIBT
$25K ﹤0.01%
4,084
+1,024
+33% +$5.57K
DNN icon
10615
PUT
Denison Mines
DNN
$2.61B
$24K ﹤0.01%
+37,600
New +$16.1K
HEPA
10616
DELISTED
Hepion Pharmaceuticals
HEPA
$24K ﹤0.01%
11
-9
-45% -$23.3K
HSDT icon
10617
Solana Company
HSDT
$98.1M
0
MATH icon
10618
Metalpha Technology Holding
MATH
$46.2M
$24K ﹤0.01%
+10,494
New +$29K
YHGJ icon
10619
Yunhong Green CTI Ltd
YHGJ
$8.06M
$24K ﹤0.01%
+1,397
New +$26.3K
CTHR
10620
DELISTED
Charles & Colvard Ltd
CTHR
$24K ﹤0.01%
+1,935
New +$20.7K
QTT
10621
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$24K ﹤0.01%
1,521
-10,135
-87% -$238K
MTL
10622
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$24K ﹤0.01%
11,792
-5,781
-33% -$9.13K
PME
10623
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$24K ﹤0.01%
+13,139
New +$27K
AMS icon
10624
American Shared Hospital Services
AMS
$9.67M
$23K ﹤0.01%
10,298
-5,607
-35% -$10.9K
GGE
10625
DELISTED
Green Giant Inc. Common Stock
GGE
$23K ﹤0.01%
+13,133
New +$20.5K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.